Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BZAM Ltd BZAMF

BZAM Ltd. is a Canadian cannabis producer with a focus on branded consumer goods. Its portfolio includes core brands, such as BZAM, TGOD, ness, Highly Dutch Organic, TABLE TOP, as well as partner brands Jeeter, Cookies, Sherbinskis, Dunn Cannabis, FRESH and Wyld. It operates facilities in British Columbia (BC), Alberta (AB), Ontario and Quebec, as well as retail stores in Regina, Saskatchewan... see more

GREY:BZAMF - Post Discussion

BZAM Ltd > News Release this a.m......
View:
Post by Iseneschal on Nov 24, 2020 8:45am

News Release this a.m......

and all the Pot stocks are up this a.m during Pre-market open in the U.S.
I honestly feel that TGOD has to do Reverse Split in order for there to be any chance for price appreciation. JMHO

TORONTONov. 24, 2020 /CNW/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (US: TGODF), a leading producer of premium certified organically grown cannabis, is pleased to announce that it has received an Export Certificate from Health Canada.  This certificate enables TGOD to complete its first shipment of medical cannabis to Germany where it will undergo stability testing, the last step before the Company can commence commercialization in 2021.

"This is an important milestone as we get ready to begin the international shipping of our certified organically grown medical cannabis products.  Germany is the first of several markets that we are planning to supply.  Other countries that we anticipate shipping to in the future are Australia and Mexico," commented Sean Bovingdon, Interim CEO of TGOD.  "We chose to obtain our EU-GMP certification from Germany because of its high standards and its progressive medical cannabis framework," added Bovingdon.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US–OTC: TGODF) is a premium certified organically grown cannabis company focused on the health and wellness market.  Its organic cannabis is cultivated in living soil, as nature intended.  The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging.  In Canada, TGOD sells dried flower and oil, and recently launched a series of next–generation cannabis products such as hash, vapes, organic teas and dissolvable powders.  Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD's Common Shares and warrants issued under the indentures dated November 1, 2017, December 19, 2019June 12, 2020 and October 23, 2020 trade on the TSX under the symbol "TGOD", "TGOD.WT", "TGOD.WS", "TGOD.WR" and "TGOD.WA", respectively, and TGODF trades in the US on the OTCQX. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Cautionary Statements

This news release includes statements containing certain "forward–looking information" within the meaning of applicable securities law ("forward–looking statements"). Forward looking statements in this release include, but are not limited to, statements about the completion of validation of the Company's products for international export, statements about the export of the Company's medical products for commercial purposes to Germany and other jurisdictions, statements about the timing of international sales of the Company's products and statements about the Company's ability to offer certain products in certain jurisdictions.  Forward–looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "should", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions.  Various assumptions were used in drawing the conclusions or making the projections contained in the forward–looking statements throughout this news release. Forward–looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward–looking statements, including those risk factors described in the Company's most recently filed Annual Information Form available on SEDAR.  The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward–looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX nor the TSX's Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

 View original content to download multimedia:https://www.prnewswire.com/news-releases/the-green-organic-dutchman-receives-health-canada-approval-to-export-medical-cannabis-to-europe-301179410.html

SOURCE The Green Organic Dutchman Holdings Ltd.

 

 View original content to download multimedia: https://www.newswire.ca/en/releases/archive/November2020/24/c8080.html

Contact:

Media Relations: Sebastien Bouchard, sbouchard@tgod.ca, (647) 272-2476; Investor Relations: Shane Dungey, sdungey@tgod.ca, (403) 389-9911

© 2020 Canjex Publishing Ltd. All rights reserved.

Comment by Reachme on Nov 24, 2020 11:20am
It's a good news but it's always the same story with TGOD...where are the sales?!?? No sales they don't make money!!!!
Comment by TruthBeTold7 on Nov 24, 2020 4:38pm
This post has been removed in accordance with Community Policy
Comment by TruthBeTold7 on Nov 25, 2020 3:44pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities